Return to search results.
Complete title: Phase I/II Adaptive Randomized Trial of Bevacizumab versus Bevacizumab plus Vorinostat in Adults with Recurrent Glioblastoma
|Research Study Number||7994|
|Principal Investigator||Marc Chamberlain, MD|
Research Study Description
The goal of this Phase II part of this clinical research study is to learn if bevacizumab when given with or without vorinostat can help to control malignant gliomas. The safety of these drug combinations will also be studied.
Eligibility Criteria (must meet the following to participate in this study)
Other eligibility criteria may apply.
Brain Cancer; Central Nervous System (CNS); Glioblastoma Multiforme; Glioma; Solid Tumors
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.